tm logo

Monitor this mark

View On USPTO

MELFLUFEN
Live/Registered
REGISTERED

on 12 Nov 2024

Last Applicant/ Owned by

Oncopeptides AB

SE-111 37 Stockholm

SE

Serial Number

79387710 filed on 19th Dec 2023

Registration Number

7561666 registered on 12th Nov 2024

in the Principal Register

Correspondent Address

London WC1R 4PQ,

UNITED KINGDOM

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

MELFLUFEN

Pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceutical, medicinal and veterinary preparations for the treatment of cancer, neoplastic diseases and multiple myeloma

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79387710

Mark Type

No Service/Collective Mark

Attorney Docket Number

No

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Status DateAction Taken
12th Dec 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
12th Nov 2024REGISTERED-PRINCIPAL REGISTER
27th Aug 2024PUBLISHED FOR OPPOSITION
07th Aug 2024NOTICE OF PUBLICATION
23rd Jul 2024APPROVED FOR PUB - PRINCIPAL REGISTER
17th Jul 2024ASSIGNED TO EXAMINER
30th Jan 2024APPLICATION FILING RECEIPT MAILED
25th Jan 2024NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23rd Jan 2024LIMITATION FROM ORIGINAL APPLICATION ENTERED
18th Jan 2024SN ASSIGNED FOR SECT 66A SUBSEQ DESIG FROM IB